PHG Stock Analysis: Buy, Sell, or Hold?
PHG - KONINKLIJKE PHILIPS N.V.
$26.30
-0.14 (-0.53%)
▼
5d:
+0.5%
30d:
-3.31%
90d:
-0.15%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Get Alerted When PHG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PHG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: PHG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.46
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$24.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHG is currently trading at $26.30, which is considered slightly low relative to its 30-day fair value range of $26.12 to $27.56. The stock's valuation (Forward PE: 13.8) is in line with its historical norms (14.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This pessimistic expectation contrasts with the company's recent 61.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHG is in a downtrend. Immediate support is located at $23.85, while resistance sits at $27.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.26 (+25.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHG is in a downtrend. Immediate support is located at $23.85, while resistance sits at $27.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.26 (+25.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$26.12 -
$27.56
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.8% below Wall St target ($33.26)
Trading Range Analysis
30-Day Trading Range
$26.12 -
$27.56
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.85
Resistance Level
$27.20
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.80
Wall Street Target
$33.26
(+25.8%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
61.4%
Profit Margin
6.3%
Valuation Discount vs History
-0.8% cheaper
PE vs Historical
13.8 vs 14.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.8%
(market-implied from PE analysis)
1-Year Target
$26.23
(-1%)
2-Year Target
$26.02
(-2%)
3-Year Target
$25.81
(-2%)
3-Yr Target (if PE normalizes)
(PE: 14→14)
$26.56
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 11.5%)
$55.28
(+109%)
Base:
(SPY PE: 13.8, Growth: 11.5%)
$36.66
(+39%)
Bear:
(PE: 11.7, Growth: 11.5%)
$31.16
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 19.62 | Current EPS (TTM): $1.33
Bull Case
$41.36
(+57%)
Analyst growth 44.1%, PE expands to 21.6
Base Case
$37.60
(+43%)
Market implied 44.1%, PE stable at 19.6
Bear Case
$17.75
(-33%)
Severe decline -20.0%, PE contracts to 16.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.8 to 14.2
Stabilization Target:
$27.21
(+2.9%)
PE Expansion Potential:
+2.9%
Share & Embed Analysis
Last updated: August 03, 2026 2:56 AM ET
Data refreshes hourly during market hours. Next update: 3:56 AM
Data refreshes hourly during market hours. Next update: 3:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
